State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China; Department of Cell Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15213, USA.
State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Cancer Lett. 2019 Dec 28;467:19-28. doi: 10.1016/j.canlet.2019.09.012. Epub 2019 Sep 26.
Krüppel-like factor 4 (KLF4) is an important transcription factor implicated in a variety of essential cellular processes. Aberrant KLF4 expression is closely related to tumourigenesis and tumour progression. The rapid turnover of the KLF4 protein indicates an important role for the posttranslational modifications (PTMs) of KLF4. To date, E3 ligases mediating KLF4 ubiquitination have been widely reported, yet the deubiquitinating mechanism of KLF4 remains largely unknown. We screened a library of 65 deubiquitinating enzymes and identified ATXN3 as a deubiquitinating enzyme of KLF4. Subsequent immunoprecipitation assays confirmed that ATXN3 bound to KLF4, mediating the deubiquitination and stabilization of KLF4 protein levels. Furthermore, we demonstrated that ATXN3 promoted breast cancer cell metastasis via KLF4 in vitro and in vivo. Finally, the protein expression analysis of human breast cancer specimens demonstrated that ATXN3 significantly correlated with KLF4. High ATXN3/KLF4 expression was associated with a poor prognosis in breast cancer patients. Collectively, we identified ATXN3 as a novel deubiquitinating enzyme of KLF4, providing a new explanation for breast cancer metastasis, and proposed ATXN3 as a potential target for breast cancer metastasis treatment.
Krüppel 样因子 4(KLF4)是一种重要的转录因子,参与多种重要的细胞过程。异常的 KLF4 表达与肿瘤发生和肿瘤进展密切相关。KLF4 蛋白的快速周转表明 KLF4 的翻译后修饰(PTMs)起着重要作用。迄今为止,介导 KLF4 泛素化的 E3 连接酶已被广泛报道,但 KLF4 的去泛素化机制在很大程度上仍不清楚。我们筛选了 65 种去泛素化酶的文库,鉴定出 ATXN3 是 KLF4 的去泛素化酶。随后的免疫沉淀实验证实 ATXN3 与 KLF4 结合,介导 KLF4 蛋白水平的去泛素化和稳定。此外,我们证明了 ATXN3 通过 KLF4 在体外和体内促进乳腺癌细胞转移。最后,对人乳腺癌标本的蛋白表达分析表明,ATXN3 与 KLF4 显著相关。高 ATXN3/KLF4 表达与乳腺癌患者预后不良相关。总之,我们确定 ATXN3 是 KLF4 的一种新型去泛素化酶,为乳腺癌转移提供了新的解释,并提出 ATXN3 可能成为乳腺癌转移治疗的靶点。